cbdMD (YCBD) Convertible Debt (2024)

cbdMD's (YCBD) quarterly Convertible Debt came in at $362021.0 in Q4 2024, down 69.09% quarter-over-quarter from $1.2 million in Q3 2024.

cbdMD (YCBD) Convertible Debt (2024) Analysis & Trends

cbdMD has disclosed Convertible Debt across 1 years of filings, most recently posting $362021.0 for Q4 2024.

Convertible Debt for Q4 2024 came in at $362021.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2024 was $362021.0 (changed N/A YoY), and the FY2024 annual result was $1.2 million, changed N/A from the prior year.
Convertible Debt came in at $362021.0 for Q4 2024 at cbdMD, down from $1.2 million in the prior quarter.
In the past five years, Convertible Debt ranged from a high of $2.7 million in Q1 2024 to a low of $362021.0 in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Teva Pharmaceutical Industries	39.72 Bn	35.98 Bn	1.97 Bn
2	Zoetis	34.61 Bn	32.67 Bn	1.62 Bn
3	United Therapeutics	24.07 Bn	21.91 Bn	648.10 Mn
4	Aurora Cannabis	16.98 Bn	16.91 Bn	33.43 Mn
5	Neurocrine Biosciences	16.64 Bn	15.32 Bn	800.70 Mn
6	Elanco Animal Health	12.19 Bn	11.76 Bn	785.00 Mn
7	Alkermes	7.37 Bn	6.86 Bn	-116.06 Mn
8	Hims & Hers Health	6.62 Bn	5.87 Bn	396.79 Mn
9	Lantheus Holdings	6.47 Bn	5.97 Bn	230.92 Mn
10	cbdMD	3,884.57	-3.38 Mn	3.00 Mn

Download Data